BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND COX6C, P09669, 1345, ENSG00000164919
15 results:

  • 1. Detection of a second primary cancer in a 18F-fluorocholine PET/CT - multicentre retrospective analysis on a group of 1345 prostate cancer patients.
    Cegla P; Scibisz-Dziedzic K; Witkowska K; Kubiak A; Wierzchoslawska E; Kycler W; Chrapko B; Czepczyński R
    Nucl Med Rev Cent East Eur; 2022; 25(1):25-30. PubMed ID: 35137934
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A validated pediatric disease risk index for allogeneic hematopoietic cell transplantation.
    Qayed M; Ahn KW; Kitko CL; Johnson MH; Shah NN; Dvorak C; Mellgren K; Friend BD; Verneris MR; Leung W; Toporski J; Levine J; Chewning J; Wayne A; Kapoor U; Triplett B; Schultz KR; Yanik GA; Eapen M
    Blood; 2021 Feb; 137(7):983-993. PubMed ID: 33206937
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The clinical and pathological features of plasma cell myeloma post solid organ transplantation.
    Ofori K; Soderquist CR; Murty VV; Park D; Vlad G; Leeman-Neill RJ; Lentzsch S; Alobeid B; Bhagat G
    Am J Hematol; 2020 Dec; 95(12):1531-1541. PubMed ID: 32864761
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Standardization of BCR-ABL1 quantification on the international scale in China using locally developed secondary reference panels.
    Zhang JW; Fu Y; Wu QS; Bao LH; Peng RX; Zhang R; Li JM
    Exp Hematol; 2020 Jan; 81():42-49.e3. PubMed ID: 31863797
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Improved survival outcomes with the addition of rituximab to initial therapy for chronic lymphocytic leukemia: a comparative effectiveness analysis in the province of British Columbia, Canada.
    Lee LJ; Toze CL; Huang SJT; Gillan TL; Connors JM; Sehn LH; Bruyere H; Leitch H; Ramadan KM; Gerrie AS
    Leuk Lymphoma; 2018 Jun; 59(6):1356-1363. PubMed ID: 29032719
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Soluble CD44 and CD44v6 and prognosis in children with B-cell acute lymphoblastic leukemia.
    Amirghofran Z; Asiaee E; Kamazani FM
    Asia Pac J Clin Oncol; 2016 Sep; 12(3):e375-82. PubMed ID: 25227983
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2.
    Nangalia J; Massie CE; Baxter EJ; Nice FL; Gundem G; Wedge DC; Avezov E; Li J; Kollmann K; Kent DG; Aziz A; Godfrey AL; Hinton J; Martincorena I; Van Loo P; Jones AV; Guglielmelli P; Tarpey P; Harding HP; Fitzpatrick JD; Goudie CT; Ortmann CA; Loughran SJ; Raine K; Jones DR; Butler AP; Teague JW; O'Meara S; McLaren S; Bianchi M; Silber Y; Dimitropoulou D; Bloxham D; Mudie L; Maddison M; Robinson B; Keohane C; Maclean C; Hill K; Orchard K; Tauro S; Du MQ; Greaves M; Bowen D; Huntly BJP; Harrison CN; Cross NCP; Ron D; Vannucchi AM; Papaemmanuil E; Campbell PJ; Green AR
    N Engl J Med; 2013 Dec; 369(25):2391-2405. PubMed ID: 24325359
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Interleukin-24 mediates apoptosis in human B-cells through early activation of cell cycle arrest followed by late induction of the mitochondrial apoptosis pathway.
    Hadife N; Nemos C; Frippiat JP; Hamadé T; Perrot A; Dalloul A
    Leuk Lymphoma; 2013 Mar; 54(3):587-97. PubMed ID: 22860893
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Glycemic index, glycemic load and cancer risk.
    Hu J; La Vecchia C; Augustin LS; Negri E; de Groh M; Morrison H; Mery L;
    Ann Oncol; 2013 Jan; 24(1):245-51. PubMed ID: 22831983
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Dietary transfatty acids and cancer risk.
    Hu J; La Vecchia C; de Groh M; Negri E; Morrison H; Mery L;
    Eur J Cancer Prev; 2011 Nov; 20(6):530-8. PubMed ID: 21701388
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Dietary cholesterol intake and cancer.
    Hu J; La Vecchia C; de Groh M; Negri E; Morrison H; Mery L;
    Ann Oncol; 2012 Feb; 23(2):491-500. PubMed ID: 21543628
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. ATRA and anthracycline-based chemotherapy in the treatment of childhood acute promyelocytic leukemia (APL): A 10-year experience in Tunisia.
    Jeddi R; Ghédira H; Ben Abdennebi Y; Kacem K; Ben Amor R; Aissaoui L; Bouterâa W; Ben Lakhal R; Ben Abid H; Menif S; Belhadjali Z; Meddeb B
    Med Oncol; 2011 Dec; 28(4):1618-23. PubMed ID: 20697840
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Pulmonary complications in patients with haematological malignancies treated at a respiratory ICU.
    Ewig S; Torres A; Riquelme R; El-Ebiary M; Rovira M; Carreras E; Raño A; Xaubet A
    Eur Respir J; 1998 Jul; 12(1):116-22. PubMed ID: 9701425
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Comparison of the cellularity and presence of residual leukemia in bone marrow aspirate and biopsy specimens in pediatric patients with acute lymphoblastic leukemia (ALL) at day 7-14 of chemotherapy.
    Kidd PG; Saminathan T; Drachtman RA; Ettinger LJ
    Med Pediatr Oncol; 1997 Dec; 29(6):541-3. PubMed ID: 9324341
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Cancer mortality at a Naval Nuclear Shipyard.
    Rinsky RA; Zumwalde RD; Waxweiler RJ; Murray WE; Bierbaum PJ; Landrigan PJ; Terpilak M; Cox C
    Lancet; 1981 Jan; 1(8214):231-5. PubMed ID: 6109897
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.